secwatch.observer — SEC 8-K summary
======================================

Issuer:     Dalrada Technology Group, Inc. (DHTI)
CIK:        0000725394
Form:       8-K/A
Filed at:   2026-02-02T23:59:59+00:00
Accession:  0001683168-26-000673
Event type: debt
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.03, 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Dalrada Tech Group amends 8-K: subsidiary Genefic secures up to $25M financing; CEO personal guaranty
--------------------------------------------------------------------------------

- Corrected total commitment from $20M to $25M: $20M SBLC agreement + $5M ARL receivables facility.
- CEO Brian Bonar provides unlimited personal guaranty; parent company pledges substantially all assets.
- Availability period through Dec 31, 2030; fees include $140k cash, $165k note, $225k warrant for 5% equity.
- Financing supports Genefic's healthcare specialty pharmacy operations.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/725394/000168316826000673/0001683168-26-000673-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/725394/000168316826000673/dalrada_8ka1.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-000673

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer